BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zarkesh M, Zadeh-Vakili A, Azizi F, Foroughi F, Akhavan MM, Hedayati M. Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes. Mol Diagn Ther 2018;22:41-56. [PMID: 28986854 DOI: 10.1007/s40291-017-0303-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Xu H, Zhang Y, Wu H, Zhou N, Li X, Pineda JP, Zhu Y, Fu H, Ying M, Yang S, Bao J, Yang L, Zhang B, Guo L, Sun L, Lu F, Wang H, Huang Y, Zhu T, Wang X, Wei Q, Sheng C, Qu S, Lv Z, Xu D, Li Q, Dong Y, Qin J, Cheng T, Xing M. High Diagnostic Accuracy of Epigenetic Imprinting Biomarkers in Thyroid Nodules. JCO 2022. [DOI: 10.1200/jco.22.00232] [Reference Citation Analysis]
2 Zarkesh M, Arab N, Abooshahab R, Heydarzadeh S, Sheikholeslami S, Nozhat Z, Salehi Jahromi M, Fanaei SA, Hedayati M. CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross-sectional study with a systematic review. Cancer Cell Int 2022;22:310. [PMID: 36221112 DOI: 10.1186/s12935-022-02720-w] [Reference Citation Analysis]
3 Zarkesh M, Arab N, Heydarzadeh S, Nozhat Z, Abooshahab R, Jahromi MS, Fanaei SA, Hedayati M. TIMP3 Gene Upstream CpG Island Methylation is Associated with BRAF V600E Mutation in Thyroid Neoplasms.. [DOI: 10.21203/rs.3.rs-2028260/v1] [Reference Citation Analysis]
4 Zarkesh M, Arab N, Abooshahab R, Heydarzadeh S, Sheikholeslami S, Nozhat Z, Jahromi MS, Fanaei SA, Hedayati M. CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross- sectional study with a systematic review.. [DOI: 10.21203/rs.3.rs-1944653/v1] [Reference Citation Analysis]
5 Ren C, Liu K, Zhao X, Guo H, Luo Y, Chang J, Gao X, Lv X, Zhi X, Wu X, Jiang H, Chen Q, Li Y. Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis. Front Pharmacol 2022;13:853289. [PMID: 35754495 DOI: 10.3389/fphar.2022.853289] [Reference Citation Analysis]
6 Heydarzadeh S, Kia SK, Zarkesh M, Pakizehkar S, Hosseinzadeh S, Hedayati M, Hrelia S. The Cross-Talk between Polyphenols and the Target Enzymes Related to Oxidative Stress-Induced Thyroid Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/2724324] [Reference Citation Analysis]
7 Heydarzadeh S, Asghar Moshtaghie A, Daneshpour M, Hedayati M. Molecular Mechanisms of Glucose Uptake Regulation in Thyroid Cancer. Hypothyroidism - New Aspects of an Old Disease 2022. [DOI: 10.5772/intechopen.101937] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zarkesh M, Arab N, Tavangar SM, Nozhat Z, Fanaei S, Hedayati M. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer. Pathology - Research and Practice 2022;229:153694. [DOI: 10.1016/j.prp.2021.153694] [Reference Citation Analysis]
9 Li X, Li L, Lei W, Chua HZ, Li Z, Huang X, Wang Q, Li N, Zhang H. Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms. Biomed Pharmacother 2021;142:111979. [PMID: 34358754 DOI: 10.1016/j.biopha.2021.111979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Mikhailova AA, Shestakov AV, Chubakova KA, Kolokolova EV, Eliseev VY, Kostyaeva MY, Akperov EG, Pilipenko VE, Saprina TV, Mukhamedov MR, Choinzonov EL. Modern concepts of the molecular pathogenesis of thyroid cancer. Usp mol onkol 2021;8:8-22. [DOI: 10.17650/2313-805x-2021-8-2-8-22] [Reference Citation Analysis]
11 Dong L, Geng Z, Liu Z, Tao M, Pan M, Lu X. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR. Pathol Res Pract 2021;225:153550. [PMID: 34340128 DOI: 10.1016/j.prp.2021.153550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Lorusso L, Cappagli V, Valerio L, Giani C, Viola D, Puleo L, Gambale C, Minaldi E, Campopiano MC, Matrone A, Bottici V, Agate L, Molinaro E, Elisei R. Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities. Int J Mol Sci 2021;22:3117. [PMID: 33803747 DOI: 10.3390/ijms22063117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
13 Liu K, Gao M, Qin D, Wang H, Lu Q. Serous BMP8A has Clinical Significance in the Ultrasonic Diagnosis of Thyroid Cancer and Promotes Thyroid Cancer Cell Progression. Endocr Metab Immune Disord Drug Targets 2020;20:591-8. [PMID: 31656161 DOI: 10.2174/1871530319666191018170022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Luzón-Toro B, Villalba-Benito L, Fernández RM, Torroglosa A, Antiñolo G, Borrego S. RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer. Orphanet J Rare Dis 2021;16:4. [PMID: 33407723 DOI: 10.1186/s13023-020-01665-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Hitu L, Gabora K, Bonci EA, Piciu A, Hitu AC, Ștefan PA, Piciu D. MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020. Cancers (Basel) 2020;12:E3118. [PMID: 33113852 DOI: 10.3390/cancers12113118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
16 Sheikholeslami S, Azizi F, Ghasemi A, Alibakhshi A, Parsa H, Tavangar SM, Shivaee S, Zarif Yeganeh M, Hedayati M, Teimoori-Toolabi L. NOL4 is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting Its Role as a Tumor Suppressor Gene. Int J Endocrinol Metab 2020;18:e108510. [PMID: 33613681 DOI: 10.5812/ijem.108510] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
17 Kachko VA, Platonova NM, Vanushko VE, Shifman BM. [The role of molecular testing in thyroid tumors]. Probl Endokrinol (Mosk) 2020;66:33-46. [PMID: 33351337 DOI: 10.14341/probl12491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Veschi V, Verona F, Lo Iacono M, D'Accardo C, Porcelli G, Turdo A, Gaggianesi M, Forte S, Giuffrida D, Memeo L, Todaro M. Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis. Front Endocrinol (Lausanne) 2020;11:566. [PMID: 32982967 DOI: 10.3389/fendo.2020.00566] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
19 Heydarzadeh S, Moshtaghie AA, Daneshpoor M, Hedayati M. Regulators of glucose uptake in thyroid cancer cell lines. Cell Commun Signal. 2020;18:83. [PMID: 32493394 DOI: 10.1186/s12964-020-00586-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
20 Tirrò E, Martorana F, Romano C, Vitale SR, Motta G, Di Gregorio S, Massimino M, Pennisi MS, Stella S, Puma A, Gianì F, Russo M, Manzella L, Vigneri P. Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice. Genes (Basel) 2019;10:E709. [PMID: 31540307 DOI: 10.3390/genes10090709] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 15.0] [Reference Citation Analysis]
21 Khatami F, Larijani B, Nasiri S, Tavangar SM. Liquid Biopsy as a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations. Int J Mol Cell Med 2019;8:19-29. [PMID: 32351906 DOI: 10.22088/IJMCM.BUMS.8.2.19] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Fiore M, Oliveri Conti G, Caltabiano R, Buffone A, Zuccarello P, Cormaci L, Cannizzaro MA, Ferrante M. Role of Emerging Environmental Risk Factors in Thyroid Cancer: A Brief Review. Int J Environ Res Public Health 2019;16:E1185. [PMID: 30986998 DOI: 10.3390/ijerph16071185] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 22.0] [Reference Citation Analysis]
23 Lin CL, Tsai ML, Lin CY, Hsu KW, Hsieh WS, Chi WM, Huang LC, Lee CH. HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer. Int J Mol Sci 2019;20:E454. [PMID: 30669676 DOI: 10.3390/ijms20020454] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
24 Tao H, Song ZY, Ding XS, Yang JJ, Shi KH, Li J. LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives. Endocrine 2018;62:281-91. [PMID: 30054866 DOI: 10.1007/s12020-018-1688-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
25 Robertson JC, Jorcyk CL, Oxford JT. DICER1 Syndrome: DICER1 Mutations in Rare Cancers. Cancers (Basel) 2018;10:E143. [PMID: 29762508 DOI: 10.3390/cancers10050143] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 16.3] [Reference Citation Analysis]
26 Tang J, Kong D, Cui Q, Wang K, Zhang D, Yuan Q, Liao X, Gong Y, Wu G. Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer. PeerJ 2018;6:e4674. [PMID: 29740512 DOI: 10.7717/peerj.4674] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]